bispecific antibodies

Merck pays $588M for bispecific to defend Keytruda’s kingdom from emerging threat
Fierce Biotech
Thu, 11/14/24 - 10:07 am
Merck
Keytruda
bispecific antibodies
LaNova Medicines
Ideaya pushes ahead with Biocytogen bispecific ADC bet
Fierce Biotech
Mon, 11/11/24 - 11:27 am
IDEAYA Biosciences
bispecific antibodies
Biocytogen
Another Roche MAGE-A4 trial disappears, withdrawn without enrolling after strategic review
Fierce Biotech
Fri, 10/18/24 - 11:34 am
Roche
MAGE-A4
clinical trials
solid tumors
bispecific antibodies
Genentech
Merck bets $700M on an antibody drug’s potential in immune diseases
BioPharma Dive
Fri, 08/9/24 - 11:57 am
Merck
autoimmune disease
Curon Biopharmaceutical
China
bispecific antibodies
BMS ditches TIGIT, walking away from $200M bet on Agenus bispecific
Fierce Biotech
Mon, 08/5/24 - 11:10 am
Bristol Myers Squibb
Tigit
Agenus
bispecific antibodies
J&J scoops up another atopic dermatitis antibody in $1.25B Numab rights deal
Fierce Biotech
Tue, 05/28/24 - 11:02 am
JNJ
atopic dermatitis
bispecific antibodies
Numab Therapeutics
ASCO24: Regeneron’s Bispecific Antibody Falls Flat in Early Study
BioSpace
Fri, 05/24/24 - 11:35 am
ASCO 2024
Regeneron
clinical trials
bispecific antibodies
REGN7075
solid tumors
J&J to buy Proteologix and its dual-targeting antibody drugs for $850M
BioPharma Dive
Thu, 05/16/24 - 11:41 am
JNJ
M&A
Proteologix
bispecific antibodies
Invenra, Astellas sign bispecific antibody discovery agreement
Pharmaceutical Business Review
Wed, 04/10/24 - 09:50 am
Astellas
Invenra
B-Body
bispecific antibodies
R&D
J&J Wins Full FDA Approval for Rybrevant, Chemo Combo in NSCLC
BioSpace
Mon, 03/4/24 - 11:48 am
JNJ
FDA
bispecific antibodies
Rybrevant
non-small cell lung cancer
AbbVie and Genmab report data from follicular lymphoma antibody trial
Clinical Trials Arena
Mon, 12/11/23 - 09:59 am
AbbVie
Genman
clinical trials
epcoritamab
bispecific antibodies
relapsed or refractory follicular lymphoma
Biotheus, BioNTech Partner on Oncology Bispecific Antibody
Contract Pharma
Mon, 11/6/23 - 07:25 pm
BioNTech
bispecific antibodies
Biotheus
Amgen’s T-Cell Engager Shows Phase II Promise in Tough to Treat Lung Cancer
BioSpace
Fri, 10/20/23 - 11:34 am
Amgen
bispecific antibodies
T-cell engager
tarlatamab
clinical trials
Roche drops oral eye disease drug after completing phase 2, pulls back from solid tumor bispecific
Fierce Biotech
Thu, 10/19/23 - 11:36 am
Roche
diabetic retinopathy
solid tumors
bispecific antibodies
Regeneron’s linvoseltamab shows early and durable response in pre-treated MM
Clinical Trials Arena
Fri, 09/29/23 - 11:38 am
Regeneron
clinical trials
bispecific antibodies
linvoseltamab
Janssen granted additional European Commission approval for bispecific antibody
Biopharma Reporter
Tue, 08/22/23 - 09:54 am
Janssen
JNJ
bispecific antibodies
Europe
relapsed or refractory multiple myeloma
Regeneron rethinks CD28 bispecific R&D plan after 2 patients die
Fierce Biotech
Thu, 08/3/23 - 10:17 am
Regeneron
prostate cancer
clinical trials
patient deaths
REGN5678
bispecific antibodies
Takeda adds another F-Star collab to constellation, this time for $1B in biobucks
Fierce Biotech
Wed, 07/5/23 - 07:06 pm
Takeda
F-star Therapeutics
bispecific antibodies
immuno-oncology
AbbVie, Genmab Bi-Specific Lymphoma Data Tee Up Potential Challenge to Roche Drug
BioSpace
Thu, 06/29/23 - 11:15 pm
AbbVie
Genmab
Roche
follicular lymphoma
bispecific antibodies
epcoritamab
Lunsumio
J&J quietly punts a pair of early-stage bispecifics for solid tumors
Endpoints
Thu, 01/26/23 - 10:45 am
JNJ
bispecific antibodies
solid tumors

Pages